artículo
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Fecha
2020Registro en:
10.1200/JCO.19.01307
0732-183X
Autor
Finn, RS
Ryoo, BY
Merle, P
Bouattour, M
Lim, HY
Breder, V
Edeline, J
Chao, Y
Ogasawara, S
Yau, T
Garrido, M
Chan, SL
Knox, J
Daniele, B
Ebbinghaus, SW
Chen, E
Siegel, AB
Zhu, AX
Cheng, AL